Alerts will be sent to your verified email
Verify EmailSANOFI
Sanofi India
|
Eris Lifesciences
|
Torrent Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Domestic Sales Growth - YoY
|
0.6 % | 6.0 % | 12.9 % |
Unclassified
|
|||
R&D as a % of Total Sales
|
0.0 | 0.0 | 5.0 % |
Financials
|
|||
5 yr Average ROE
|
43.25 % | 21.87 % | 20.0 % |
5yr average Equity Multiplier
|
3.33 | 1.23 | 2.34 |
5yr Average Asset Turnover Ratio
|
0.57 | 0.65 | 0.65 |
5yr Avg Net Profit Margin
|
22.99 % | 27.87 % | 13.21 % |
Price to Book
|
14.97 | 5.47 | 13.93 |
P/E
|
27.67 | 36.06 | 57.64 |
5yr Avg Cash Conversion Cycle
|
11.11 Days | -52.94 Days | -189.03 Days |
Inventory Days
|
48.47 Days | 26.19 Days | 54.5 Days |
Days Receivable
|
13.83 Days | 46.91 Days | 41.38 Days |
Days Payable
|
55.71 Days | 168.01 Days | 318.84 Days |
5yr Average Interest Coverage Ratio
|
1007.93 | 96.59 | 5.79 |
5yr Avg ROCE
|
29.56 % | 24.86 % | 23.72 % |
5yr Avg Operating Profit Margin
|
28.62 % | 36.16 % | 30.68 % |
5 yr average Debt to Equity
|
0.0 | 0.11 | 0.83 |
5yr CAGR Net Profit
|
41.96 % | 5.62 % | 10.08 % |
5yr Average Return on Assets
|
13.01 % | 18.27 % | 8.58 % |
Shareholdings
|
|||
Promoter Holding
|
60.4 % | 54.9 % | 71.25 % |
Share Pledged by Promoters
|
0.0 | 18.51 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.77 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
1.86 % | 5.69 % | -2.01 % |
Sanofi India
|
Eris Lifesciences
|
Torrent Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
-
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|